GLP-1 Questions Every Patient Is Asking

Why Everyone Seems to Have the Same GLP-1 Questions

You have probably heard about Ozempic or Wegovy from a friend, a headline, or your own doctor. And if you are doing your research before starting, you likely have a list of questions that feels a mile long.

The good news is that most people researching GLP-1 medications ask almost the same things. Physicians who prescribe these medications regularly say the same concerns come up in nearly every patient conversation. That means you are not overthinking it. You are asking exactly the right things.

This article addresses those questions directly, with the kind of plain-language answers you actually need before making a decision.

Am I Actually Eligible for a GLP-1 Medication?

This is almost always the first question, and the answer depends on which medication you are asking about and why you want it.

For weight loss (obesity treatment)

The FDA has approved Wegovy (semaglutide 2.4 mg) and Mounjaro / Zepbound (tirzepatide) for chronic weight management. The general eligibility criteria are:

• A body mass index (BMI) of 30 or higher, OR
• A BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or sleep apnea

For type 2 diabetes

Ozempic (semaglutide 1 mg or 2 mg) is FDA-approved specifically for adults with type 2 diabetes to improve blood sugar control and reduce cardiovascular risk.

If you fall outside these categories, a prescriber may still consider an off-label approach, but that conversation belongs between you and your physician. The first step is an honest health history review, which most telehealth platforms and in-person providers will walk you through before writing any prescription.

How Do These Medications Actually Work?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after you eat. It signals your brain that you are full, slows digestion, and tells your pancreas to release insulin when blood sugar rises.

GLP-1 receptor agonists mimic this hormone and keep it active much longer than your body normally would. The result is that you feel fuller faster, stay full longer, and experience fewer food cravings throughout the day.

Tirzepatide (the active ingredient in Mounjaro and Zepbound) adds a second mechanism. It also activates GIP receptors, another gut hormone, which may explain why clinical trials showed slightly higher average weight loss with tirzepatide compared to semaglutide.

None of this is magic. These drugs amplify hormonal signals your body already uses. They work best when you are also paying attention to what you eat and staying active.

What Side Effects Should I Actually Expect?

Nausea is the most commonly reported side effect, and it is the one that causes most people to hesitate. But context matters.

Most people experience nausea most during the first few weeks of treatment and especially after each dose increase. The prescribing protocols for both semaglutide and tirzepatide are designed specifically to minimize this. You start on a very low dose and gradually increase over several months.

Common side effects include:

• Nausea (most frequent, usually mild to moderate)
• Vomiting (less common, usually tied to eating too much or too quickly)
• Constipation or diarrhea
• Fatigue, particularly in the first few weeks
• Acid reflux or indigestion

Serious side effects are rare but real. These include pancreatitis (inflammation of the pancreas), gallbladder problems, and a rare type of thyroid tumor seen in animal studies. People with a personal or family history of medullary thyroid carcinoma or a condition called MEN2 should not take these medications.

Your prescriber will go through your full health history before starting you on any GLP-1 therapy. If you have concerns about a specific risk factor, that is exactly the conversation to have upfront.

How Long Until I See Results?

Patience is genuinely required here, and it helps to know what the typical timeline looks like.

The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide both showed that meaningful weight loss tends to accumulate over 68 to 72 weeks. This is not a quick fix, and setting realistic expectations early tends to improve long-term success.

What Does GLP-1 Medication Actually Cost?

This is where things get complicated, and it is one of the most important practical questions to get answered before you start.

With insurance coverage

Brand-name GLP-1 medications are expensive. Without coverage, Wegovy and Ozempic can run $900 to over $1,300 per month. Insurance coverage for weight loss medications specifically is inconsistent. Many plans cover Ozempic for diabetes but not Wegovy for weight loss, even though they contain the same active ingredient at different doses.

Manufacturer savings programs

Novo Nordisk (maker of Ozempic and Wegovy) and Eli Lilly (maker of Mounjaro and Zepbound) both offer savings cards for eligible commercially insured patients. These can reduce costs significantly, sometimes to under $25 per month for qualifying individuals.

Compounded semaglutide and tirzepatide

During periods of FDA-designated drug shortages, compounding pharmacies were permitted to produce versions of semaglutide and tirzepatide at significantly lower prices, often $150 to $400 per month. The FDA shortage status for both drugs has changed over time, which affects compounding availability. This is an area worth asking your provider about directly, since the rules shift.

Telehealth platforms

Many telehealth providers that specialize in GLP-1 prescribing bundle the medication cost into a monthly subscription that includes clinical oversight. This can be cost-effective depending on your insurance situation. You can compare options on the Best Providers page to see current pricing.

You can also explore the GLP-1 Coupons page for savings options that are currently active.

Do I Have to Stay on It Forever?

This is one of the most common and most honest questions patients ask, and it deserves a direct answer.

For most people, GLP-1 medications are a long-term treatment, not a short-term intervention. The clinical evidence consistently shows that people who stop taking these medications tend to regain a significant portion of their lost weight within 12 months.

A 2022 study published in Diabetes, Obesity and Metabolism found that participants who stopped semaglutide after 68 weeks regained about two-thirds of the weight they had lost within a year of stopping.

This does not mean you must be on it forever. Some people do manage to maintain lower weights after stopping, particularly if they have made durable lifestyle changes. But it is worth going into treatment with honest expectations. This is closer to how we think about blood pressure medication than a course of antibiotics.

The right framing is this: obesity is a chronic condition. Long-term management is not a failure. It is appropriate medical care.

Can I Get a Prescription Without Seeing a Specialist?

Yes, and this is something that has genuinely changed access to GLP-1 therapy for a lot of people.

Primary care physicians can and do prescribe GLP-1 medications. You do not need an endocrinologist or a bariatric specialist unless your situation is complex. If your primary care provider is not comfortable prescribing these medications or is not up to date on the current evidence, that is a reasonable reason to seek a second opinion or explore telehealth options.

Telehealth platforms that specialize in metabolic health and weight management have made it possible to complete an evaluation, receive a prescription, and have medication delivered to your home without ever visiting a clinic. These platforms typically include ongoing provider check-ins and dose management as part of their service.

When evaluating a telehealth provider, look for:

• Licensed prescribers in your state
• Clear protocols for dose escalation and side effect management
• Transparent pricing with no hidden fees
• Access to a care team if side effects arise

You can review vetted options at Best Providers.

What Questions Should You Bring to Your Next Appointment?

Before your first conversation with a provider, whether in person or through a telehealth platform, it helps to arrive prepared. Here are the most useful things to ask:

1. Am I eligible based on my current BMI and health history?
2. Which medication would you recommend for my specific situation, and why?
3. How will we handle side effects if they become difficult to manage?
4. What does the dose escalation schedule look like, and how long does it take?
5. What should I do if I miss a dose or need to pause treatment?
6. How will we measure progress beyond the number on the scale?
7. What is the plan if I reach my goal weight or want to eventually stop?

These are not difficult questions, and any competent prescriber should be able to answer them clearly. If a provider brushes past your concerns or rushes through the intake process, that is worth noting.

The Bottom Line

GLP-1 medications like semaglutide and tirzepatide represent a meaningful shift in how chronic weight management is approached medically. They are not perfect, they are not cheap, and they are not for everyone. But for the right patient with the right support, the clinical evidence is genuinely strong.

The questions you are asking right now, about safety, cost, eligibility, and long-term use, are the right questions. The answers should come from a provider who takes the time to understand your full health picture, not just your BMI.

If you are still comparing options or trying to figure out where to start, GLP-1.com has resources built specifically for this stage of the process. You can compare top-rated providers at Best Providers, explore current savings options at GLP-1 Coupons, and read detailed breakdowns of individual medications including Ozempic, Wegovy, and Mounjaro.

As always, consult your physician or a qualified prescriber before starting, adjusting, or stopping any medication.